Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · IEX Real-Time Price · USD
0.890
-0.034 (-3.67%)
At close: Jul 2, 2024, 4:00 PM
0.880
-0.010 (-1.09%)
After-hours: Jul 2, 2024, 7:38 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $32.85 million as of July 2, 2024. Its market cap has decreased by -56.37% in one year.
Market Cap
32.85M
Enterprise Value
5.05M
1-Year Change
-56.37%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $32.85M, a decrease of -92.30%. That is a compound annual growth rate of -61.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 34.10M | 125.83% |
| Dec 29, 2023 | 15.10M | -79.57% |
| Dec 30, 2022 | 73.90M | -83.19% |
| Dec 31, 2021 | 439.50M | 3.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DarioHealth | 35.61M |
| Acurx Pharmaceuticals | 35.60M |
| IceCure Medical | 35.48M |
| IRIDEX | 35.11M |
| Surrozen | 35.03M |
| Fortress Biotech | 34.90M |
| Vicarious Surgical | 34.51M |
| iCAD, Inc. | 34.50M |